Japan: First large-scale clinical study of cancer vaccine

a large-scale joint clinical study of the cancer vaccine recently conducted byof severalhospitals in Japan, with the aim of using the vaccine to activate immune cells to attack cancer cells and prevent cancer recurrence after surgerySome patients have now been vaccinatedAccording to Japanese media reported on the 7th, the large-scale clinical study by 13 universities affiliatedhospitalsand some cancer specialisthospitalsconcrete implementation, this study will verify the effectiveness of cancer vaccine, the types of cancer, including pancreatic cancer,esophageal cancer,liver cancer,stomach cancer and lung cancerThe cancer vaccine used in this clinical study was developed by the Human Gene Analysis Center of the Institute of Medical Sciences of the University of TokyoThe center find certain specific genes by studying genetic information humans They are "silent" normal cells, but but are "active" in cancer cells The researchers have developed targeted vaccine that to activate human immune cells to attack cancer cells , prevent relapse in cancer patients Although there have been a few hospitals in Japan have conducted clinical research on cancer vaccines , but this large-scale joint study is the first And similar clinical studies have previously been targeted at patients with advanced cancer, and because of the patient's physical reasons, the cancer vaccine is difficult to activate immune cells And this study is to prevent relapse as the ultimate goal, so the test object is relatively good after surgery patients, so easy to produce immune response (
Xinhua News Agency, without permission, it is strictly prohibited to reproduce)